Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Hovden AO"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Durheim MT; Institute for Clinical Medicine, University of Oslo, Oslo, Norway michael.durheim@medisin.uio.no.; Department of Respiratory Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway., Hoffmann-Vold AM; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Rheumatology, Oslo University Hospital - Rikshospitalet, Oslo, Norway., Eagan TM; Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Hovden AO; Boehringer Ingelheim Norway KS, Asker, Norway., Lund MB; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Respiratory Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway., Bjerke G; Department of Pulmonary Medicine, Akershus University Hospital, Lorenskog, Norway., Birring SS; Department of Respiratory Medicine, King's College Hospital, London, UK., Jonassen TM; Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Johansen OE; Boehringer Ingelheim Norway KS, Asker, Norway., Sjåheim T; Department of Respiratory Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway.
Publikováno v:
BMJ open respiratory research [BMJ Open Respir Res] 2020 Jun; Vol. 7 (1).
Autor:
Herrera-Rodriguez J; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Meijerhof T; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Niesters HG; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Stjernholm G; Bionor Pharma AS, P.O. Box 1477 Vika, NO-0116 Oslo, Norway., Hovden AO; Bionor Pharma AS, P.O. Box 1477 Vika, NO-0116 Oslo, Norway., Sørensen B; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Bionor Pharma AS, P.O. Box 1477 Vika, NO-0116 Oslo, Norway., Ökvist M; Bionor Pharma AS, P.O. Box 1477 Vika, NO-0116 Oslo, Norway., Sommerfelt MA; Bionor Pharma AS, P.O. Box 1477 Vika, NO-0116 Oslo, Norway., Huckriede A; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: a.l.w.huckriede@umcg.nl.
Publikováno v:
Virology [Virology] 2018 Feb; Vol. 515, pp. 21-28. Date of Electronic Publication: 2017 Dec 07.
Autor:
Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, M2-C200, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: yunda@scharp.org., Pantaleo G; Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, BH10-527, CH-1011 Lausanne, Switzerland. Electronic address: Giuseppe.Pantaleo@chuv.ch., Tapia G; Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, BH10-527, CH-1011 Lausanne, Switzerland. Electronic address: Gonzalo.Tapia@chuv.ch., Sanchez B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, M2-C200, WA, USA. Electronic address: bprigmore@scharp.org., Zhang L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, M2-C200, WA, USA. Electronic address: yzhang2@scharp.org., Trondsen M; Bionor Pharma AS, P.O. Box 1477 Vika, NO-0116 Oslo, Norway. Electronic address: monica.trondsen@gmail.com., Hovden AO; Bionor Pharma AS, P.O. Box 1477 Vika, NO-0116 Oslo, Norway. Electronic address: arntovehovden@gmail.com., Pollard R; University of California, Davis School of Medicine, 4150 V Street, Suite G500 PSSB, 95817 Sacramento, CA, USA. Electronic address: rbpollard@ucdavis.edu., Rockstroh J; Oberarzt an der Medizinischen Universitätsklinik, Innere-Rheuma-Tropen Ambulanz, Sigmund-Freud-Str. 25, 53105 Bonn, Venusberg, Germany. Electronic address: Juergen.Rockstroh@ukb.uni-bonn.de., Ökvist M; Bionor Pharma AS, P.O. Box 1477 Vika, NO-0116 Oslo, Norway. Electronic address: mo@bionorpharma.com., Sommerfelt MA; Bionor Pharma AS, P.O. Box 1477 Vika, NO-0116 Oslo, Norway. Electronic address: ms@bionorpharma.com.
Publikováno v:
EBioMedicine [EBioMedicine] 2017 Oct; Vol. 24, pp. 195-204. Date of Electronic Publication: 2017 Sep 22.
Autor:
Sørensen B; 1 Bionor Pharma AS , Oslo, Norway ., Sommerfelt MA; 1 Bionor Pharma AS , Oslo, Norway ., Stjernholm G; 1 Bionor Pharma AS , Oslo, Norway ., Smith PL; 2 St. George's, University of London , Institute of Infection and Immunity, London, United Kingdom ., Ökvist M; 1 Bionor Pharma AS , Oslo, Norway ., Hovden AO; 1 Bionor Pharma AS , Oslo, Norway ., Hoddevik G; 3 Department of Virology, The Norwegian Institute of Public Health , Oslo, Norway ., Redfield R; 4 Department of Medicine, Institute of Human Virology, University of Maryland School of Medicine , Baltimore, Maryland., Ustina V; 5 State Reference Laboratory of HIV Diagnostics, West-Tallinn Central Hospital , Estonia ., Jelmert Ø; 6 Bionor Laboratories AS , Skien, Norway ., Zeldis J; 7 Celgene Corp./Celgene Global Health , Summit, New Jersey., Dalgleish A; 2 St. George's, University of London , Institute of Infection and Immunity, London, United Kingdom .
Publikováno v:
AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2017 Jun; Vol. 33 (6), pp. 558-566. Date of Electronic Publication: 2017 Jan 31.
Autor:
Smith PL; Institute of Infection and Immunity, St Georges' University of London, Cranmer Terrace, London SW17 0RE, United Kingdom., Norgate KJ, Hegarty E, Gregeda N, Heelas E, Sommerfelt M, Lange T, Hovden AO, Sorenson B, Dalgleish AG, Bodman-Smith M
Publikováno v:
Current HIV research [Curr HIV Res] 2017; Vol. 15 (1), pp. 3-14.
Autor:
Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: Yunda@fhcrc.org., Zhang L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Jolliffe D; S-cubed Biometrics Ltd, Oxfordshire, United Kingdom., Hovden AO; Bionor Pharma ASA, Oslo, Norway., Ökvist M; Bionor Pharma ASA, Oslo, Norway., Pantaleo G; Lausanne University Hospital, Lausanne, Switzerland., Sommerfelt MA; Bionor Pharma ASA, Oslo, Norway. Electronic address: ms@bionorpharma.com.
Publikováno v:
Vaccine [Vaccine] 2016 Mar 04; Vol. 34 (10), pp. 1282-8. Date of Electronic Publication: 2016 Jan 27.
Autor:
Pollard RB; Division of Infectious Diseases, UC Davis Medical Center, Sacramento, CA, USA., Rockstroh JK; Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik I, Immunologische Ambulanz, Bonn, Germany., Pantaleo G; Division of Immunology and Allergy, Lausanne University Hospital, Lausanne, Switzerland., Asmuth DM; Division of Infectious Diseases, UC Davis Medical Center, Sacramento, CA, USA., Peters B; Harrison Wing, St Thomas' Hospital, London, UK., Lazzarin A; Department of Infectious Diseases, Ospedale San Raffaele and Vita-Salute University, Milan, Italy., Garcia F; Infectious Diseases and AIDS Units, Hospital Clinic/IDIBAPS, University of Barcelona, Barcelona, Spain., Ellefsen K; Division of Immunology and Allergy, Lausanne University Hospital, Lausanne, Switzerland., Podzamczer D; HIV Unit, Infectious Disease Service, Hospital Universitari de Bellvitge, Barcelona, Spain., van Lunzen J; Universitätsklinikum Hamburg Eppendorf, Ambulanzzentrum Infektiologie, Hamburg, Germany., Arastéh K; EPIMED-Gesellschaft für Epidemiologische und Klinische Forschung in der Medizin mbH/Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany., Schürmann D; Department of Internal Medicine, Division of Infectious Diseases and Pulmonary Medicine, Charité-University Medicine Berlin, Berlin, Germany., Clotet B; Irsicaixa Foundation, UAB, UVic, Hospital Universitari 'Germans Trias i Pujol', Badalona, Catalonia, Spain., Hardy WD; Division of Infectious Diseases Cedars-Sinai Medical Center, Los Angeles, CA, USA., Mitsuyasu R; UCLA CARE Center, University of California, Los Angeles, CA, USA., Moyle G; Kobler Clinic, Chelsea and Westminster Hospital, London, UK., Plettenberg A; ifi-Institut, an der Asklepios-Klinik St Georg, Hamburg, Germany., Fisher M; Brighton and Sussex University Hospital, HIV/GUM Research, Elton John Centre, Brighton, UK., Fätkenheuer G; Klinik I für Innere Medizin, Klinikum der Universität zu Köln, Cologne, Germany., Fischl M; University of Miami School of Medicine AIDS Clinical Research Unit, Miami, FL, USA., Taiwo B; Division of Infectious Diseases, Northwestern University, Chicago, IL, USA., Baksaas I; Mericon AS, Skien, Norway., Jolliffe D; Aptiv Solutions, Abingdon, UK., Persson S; SP PharmaConsulting, Uppsala, Sweden., Jelmert O; Bionor Laboratories, Skien, Norway., Hovden AO; Bionor Pharma ASA, Oslo, Norway., Sommerfelt MA; Bionor Pharma ASA, Oslo, Norway., Wendel-Hansen V; Bionor Pharma ASA, Oslo, Norway. Electronic address: post@bionorpharma.com., Sørensen B; Bionor Pharma ASA, Oslo, Norway.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2014 Apr; Vol. 14 (4), pp. 291-300. Date of Electronic Publication: 2014 Feb 11.